XML 60 R42.htm IDEA: XBRL DOCUMENT v3.24.0.1
Stockholders' Equity (Tables)
12 Months Ended
Dec. 29, 2023
Stockholders' Equity Note [Abstract]  
Schedule of Share-based Compensation, Fair Value of Stock-Based Compensation Granted

The following table represents the fair value of stock-based compensation granted during the year ended 2023 (in thousands):

 

 

 

Fair Value

 

Stock options

 

$

21,239

 

RSUs

 

 

17,227

 

PSUs

 

 

10,338

 

Restricted stock

 

 

715

 

Total stock-based compensation expense

 

$

49,519

 

Schedule of Compensation Cost

The Company recorded stock-based compensation expense by award as follows (in thousands):

 

 

 

Years Ended

 

 

 

2023

 

 

2022

 

 

2021

 

Employee stock options

 

$

12,842

 

 

$

10,403

 

 

$

10,373

 

Restricted stock

 

 

548

 

 

 

686

 

 

 

616

 

RSUs

 

 

7,987

 

 

 

4,512

 

 

 

2,667

 

PSUs

 

 

1,270

 

 

 

3,525

 

 

 

371

 

Nonemployee stock options

 

 

869

 

 

 

1,245

 

 

 

578

 

Total stock-based compensation expense

 

$

23,516

 

 

$

20,371

 

 

$

14,605

 

Schedule of Employee Service Share-based Compensation, Allocation of Recognized Period Costs

The Company recorded stock-based compensation expense in the following categories (in thousands):

 

 

 

Years Ended

 

 

 

2023

 

 

2022

 

 

2021

 

Cost of sales

 

$

716

 

 

$

501

 

 

$

215

 

General and administrative

 

 

12,125

 

 

 

9,402

 

 

 

6,495

 

Selling and marketing

 

 

4,083

 

 

 

4,795

 

 

 

3,454

 

Research and development

 

 

6,592

 

 

 

5,673

 

 

 

4,441

 

Total stock-based compensation expense, net

 

 

23,516

 

 

 

20,371

 

 

 

14,605

 

Amounts capitalized as part of inventory

 

 

1,672

 

 

 

1,881

 

 

 

1,295

 

Total stock-based compensation expense, gross

 

$

25,188

 

 

$

22,252

 

 

$

15,900

 

Schedule of Unrecognized Compensation Cost, Non-Vested Stock-Based Compensation Arrangements

As of December 29, 2023, total unrecognized compensation cost related to non-vested stock-based compensation arrangements granted under the Equity Plan were as follows (in thousands):

 

 

 

2023

 

Stock options

 

$

22,001

 

Restricted stock, RSUs and PSUs

 

 

16,952

 

Total unrecognized stock-based compensation cost

 

$

38,953

 

Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions The risk-free rate is based on the U.S. Treasury yield curve corresponding to the expected term at the time of the grant.

 

 

Years Ended

 

 

 

2023

 

 

2022

 

 

2021

 

Expected dividend yield

 

 

0

%

 

 

0

%

 

 

0

%

Expected volatility

 

 

60

%

 

 

54

%

 

 

53

%

Risk-free interest rate

 

 

3.98

%

 

 

2.09

%

 

 

0.84

%

Expected term (in years)

 

 

5.05

 

 

 

5.10

 

 

 

5.38

 

Schedule of Share-based Compensation, Stock Options, Activity

A summary of stock option activity under the Equity Plan for the year ended December 29, 2023 was as follows:

 

 

 

Shares
(in 000’s)

 

 

Weighted-
Average
Exercise
Price

 

 

Weighted-
Average
Remaining
Contractual
Term (years)

 

 

Aggregate
Intrinsic
Value
(in 000’s)

 

Outstanding at December 30, 2022

 

 

2,469

 

 

$

39.63

 

 

 

 

 

 

 

Granted

 

 

749

 

 

 

51.88

 

 

 

 

 

 

 

Exercised

 

 

(518

)

 

 

18.67

 

 

 

 

 

 

 

Forfeited or expired

 

 

(70

)

 

 

72.30

 

 

 

 

 

 

 

Outstanding at December 29, 2023

 

 

2,630

 

 

$

46.38

 

 

 

6.04

 

 

$

10,088

 

Exercisable at December 29, 2023

 

 

1,704

 

 

$

40.70

 

 

 

4.55

 

 

$

10,088

 

Share-based Compensation, Performance Shares Award Unvested Activity

A summary of unvested stock options activity under the Equity Plan for the year ended December 29, 2023 was as follows:

 

 

 

Shares
(in 000’s)

 

 

Weighted-
Average
Grant-Date
Fair Value

 

Outstanding at December 30, 2022

 

 

633

 

 

$

35.37

 

Granted

 

 

749

 

 

 

28.36

 

Forfeited or expired

 

 

(70

)

 

 

35.30

 

Vested

 

 

(386

)

 

 

34.63

 

Unvested at December 29, 2023

 

 

926

 

 

$

30.09

 

Summary of Weighted Average Grant Date Fair Value of Stock Options Granted Under The Equity Plan and Total intrinsic Value of Stock options Exercised

The weighted average grant date fair value of stock options granted under the Equity Plan and the total intrinsic value of stock options exercised were as follows:

 

 

Years Ended

 

 

 

2023

 

 

2022

 

 

2021

 

Weighted-average grant-date fair value

 

$

28.36

 

 

$

35.68

 

 

$

45.08

 

Intrinsic value of options exercised (in thousands)

 

$

17,041

 

 

$

25,000

 

 

$

127,024

 

Schedule of Share-based Compensation, Restricted Stock, RSU and PSU Activity

A summary of restricted stock, RSU and PSU activity under the Equity Plan for the year ended December 29, 2023 was as follows:

 

 

 

Restricted Stock

 

 

Restricted Stock Units

 

 

Performance Stock Units

 

 

 

Units
(in 000’s)

 

 

Weighted-
Average Grant-
Date Fair Value

 

 

Units
(in 000’s)

 

 

Weighted-
Average Grant-
Date Fair Value

 

 

Units
(in 000’s)

 

 

Weighted-
Average Grant-
Date Fair Value

 

Outstanding at December 30, 2022

 

 

4

 

 

$

62.10

 

 

 

192

 

 

$

73.25

 

 

 

118

 

 

$

73.78

 

Granted

 

 

15

 

 

 

46.70

 

 

 

336

 

 

 

51.28

 

 

 

182

 

 

 

56.64

 

Vested

 

 

(5

)

 

 

55.99

 

 

 

(95

)

 

 

68.43

 

 

 

(35

)

 

 

71.41

 

Forfeited or expired

 

 

 

 

 

 

 

 

(32

)

 

 

75.86

 

 

 

(209

)

 

 

58.93

 

Outstanding at December 29, 2023

 

 

14

 

 

$

47.61

 

 

 

401

 

 

$

55.75

 

 

 

56

 

 

$

74.80